Chemokine Gene-modified Cells for Cancer Immunotherapy
Described herein are methods of cancer immunotherapy, particularly compositions comprising genetically-modified cells that express macrophage colony stimulating factor (GM-CSF), CD40 ligand (CD40L), and chemokine C-C motif ligand 21 (CCL21), wherein the population of cells comprises bystander cells and target cancer cells, and methods of making these compositions and treating cancer using these compositions.
ANTONIA SCOTT JOSEPH [US]; MULE JAMES J [US]
Type of Offer:
« More Genetics Patents